Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


The Effects of Lycopene and Insulin on Histological Changes and the Expression Level of Bcl-2 Family Genes in the Hippocampus of Streptozotocin-Induced Diabetic Rats.

Soleymaninejad M, Joursaraei SG, Feizi F, Jafari Anarkooli I.

J Diabetes Res. 2017;2017:4650939. doi: 10.1155/2017/4650939. Epub 2017 Jun 1.


The Effect of Green Tea Extract on Oxidative Stress and Spatial Learning in Streptozotocin-diabetic Rats.

Sharifzadeh M, Ranjbar A, Hosseini A, Khanavi M.

Iran J Pharm Res. 2017 Winter;16(1):201-209.


Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Duarte JM.

Aging Dis. 2015 Oct 1;6(5):304-21. doi: 10.14336/AD.2014.1104. eCollection 2015 Sep. Review.


Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children.

Rodrigues Vilela V, de Castro Ruiz Marques A, Schamber CR, Bazotte RB.

ScientificWorldJournal. 2014 Mar 23;2014:616534. doi: 10.1155/2014/616534. eCollection 2014. Review.


Antecedent glycemic control reduces severe hypoglycemia-induced neuronal damage in diabetic rats.

Reno CM, Tanoli T, Bree A, Daphna-Iken D, Cui C, Maloney SE, Wozniak DF, Fisher SJ.

Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1331-7. doi: 10.1152/ajpendo.00084.2013. Epub 2013 Apr 16.


A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder.

Baskaran A, Milev R, McIntyre RS.

Neuropsychiatr Dis Treat. 2013;9:143-50. doi: 10.2147/NDT.S38720. Epub 2013 Jan 17.


Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression.

Lyoo IK, Yoon S, Jacobson AM, Hwang J, Musen G, Kim JE, Simonson DC, Bae S, Bolo N, Kim DJ, Weinger K, Lee JH, Ryan CM, Renshaw PF.

Arch Gen Psychiatry. 2012 Dec;69(12):1267-76. doi: 10.1001/archgenpsychiatry.2012.543.


Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

Silverstein JM, Musikantow D, Puente EC, Daphna-Iken D, Bree AJ, Fisher SJ.

Neurosci Lett. 2011 Mar 29;492(1):23-8. doi: 10.1016/j.neulet.2011.01.045. Epub 2011 Jan 25.


Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.

Puente EC, Silverstein J, Bree AJ, Musikantow DR, Wozniak DF, Maloney S, Daphna-Iken D, Fisher SJ.

Diabetes. 2010 Apr;59(4):1055-62. doi: 10.2337/db09-1495. Epub 2010 Jan 19.


Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.

Sima AA, Zhang W, Muzik O, Kreipke CW, Rafols JA, Hoffman WH.

Rev Diabet Stud. 2009 Fall;6(3):211-22. doi: 10.1900/RDS.2009.6.211. Epub 2009 Nov 10.


Diabetes increases brain damage caused by severe hypoglycemia.

Bree AJ, Puente EC, Daphna-Iken D, Fisher SJ.

Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E194-201. doi: 10.1152/ajpendo.91041.2008. Epub 2009 May 12.


The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.

Sima AA, Zhang W, Li ZG, Kamiya H.

Exp Diabetes Res. 2008;2008:230458. doi: 10.1155/2008/230458. Review.


Diabetes and Alzheimer's disease - is there a connection?

Sima AA, Li ZG.

Rev Diabet Stud. 2006 Winter;3(4):161-8. Epub 2007 Feb 10.


Long-term effect of diabetes and its treatment on cognitive function.

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J.

N Engl J Med. 2007 May 3;356(18):1842-52. Erratum in: N Engl J Med. 2009 Nov 5;361(19):1914.

Supplemental Content

Support Center